{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:02:14Z","timestamp":1790949734051,"version":"4.1.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01198","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:15:19Z","timestamp":1559124919000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":65,"title":["Autoreactive T-Lymphocytes in Inflammatory Skin Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Wolf-Henning","family":"Boehncke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo Costantino","family":"Brembilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17248","DOI":"10.1073\/pnas.1402724111","article-title":"Optimal T-cell receptor affinity for inducing autoimmunity","volume":"111","author":"Koehli","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2249.2010.04316.x","article-title":"Expression and function of the autoimmune regulator (Aire) gene in non-thymic tissue","volume":"163","author":"Eldershaw","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.it.2015.12.005","article-title":"Re-examining the nature and function of self-reactive T cells","volume":"37","author":"Richards","year":"2016","journal-title":"Trends Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ni.1817","article-title":"Mechanisms maintaining peripheral tolerance","volume":"11","author":"Mueller","year":"2010","journal-title":"Nat Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12160","article-title":"tTregs, pTregs, and iTregs: similarities and differences","volume":"259","author":"Shevach","year":"2014","journal-title":"Immunol Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.immuni.2015.05.001","article-title":"Clonal deletion prunes but does not eliminate self-specific alphabeta CD8(+) T lymphocytes","volume":"42","author":"Yu","year":"2015","journal-title":"Immunity."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.4049\/jimmunol.1500880","article-title":"The contained self-reactive peripheral T cell repertoire: size, diversity, and cellular composition","volume":"195","author":"Richards","year":"2015","journal-title":"J Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fimmu.2014.00206","article-title":"Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1","volume":"5","author":"Kong","year":"2014","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jaci.2018.12.1011","article-title":"Regulatory cells in the skin: pathophysiological role and potential targets for anti-inflammatory therapies","volume":"143","author":"Uttarkar","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2018.01.053","article-title":"Fine-mapping analysis of the MHC region for vitiligo based on a new Han-MHC reference panel","volume":"648","author":"Yang","year":"2018","journal-title":"Gene."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.12659\/MSM.910515","article-title":"Identification of the risk HLA-A alleles and autoantigen in han chinese vitiligo patients and the association of CD8+T cell reactivity with disease characteristics","volume":"24","author":"Yi","year":"2018","journal-title":"Med Sci Monit."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European dermatology forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study","volume":"135","author":"Cavalie","year":"2015","journal-title":"J Invest Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"269rv261","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a Expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity."},{"key":"B19","doi-asserted-by":"publisher","first-page":"eaam6346","DOI":"10.1126\/sciimmunol.aam6346","article-title":"Resident memory T cells in the skin mediate durable immunity to melanoma","volume":"2","author":"Malik","year":"2017","journal-title":"Sci Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"eaam7710","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia areata: a comprehensive review of pathogenesis and management","volume":"54","author":"Trueb","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1468-3083.2006.01676.x","article-title":"Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history","volume":"20","author":"Goh","year":"2006","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/CCID.S10182","article-title":"Alopecia: evaluation and treatment","volume":"4","author":"Gordon","year":"2011","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00000658-197211000-00004","article-title":"Analysis of local anatomic factors that influence the survival times of pure epidermal and full-thickness skin homografts in guinea pigs","volume":"176","author":"Barker","year":"1972","journal-title":"Ann Surg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/46938","article-title":"Trans-gender induction of hair follicles","volume":"402","author":"Reynolds","year":"1999","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1172\/JCI551","article-title":"Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice","volume":"101","author":"Gilhar","year":"1998","journal-title":"J Clin Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/archderm.138.7.916","article-title":"Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice","volume":"138","author":"Gilhar","year":"2002","journal-title":"Arch Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/1523-1747.ep12382416","article-title":"Alopecia areata in aging C3H\/HeJ mice","volume":"102","author":"Sundberg","year":"1994","journal-title":"J Invest Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jid.2016.04.004","article-title":"Identification of autoantigen epitopes in alopecia areata","volume":"136","author":"Wang","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/379777a0","article-title":"Pulling the trigger on psoriasis","volume":"379","author":"Boehncke","year":"1996","journal-title":"Nature."},{"key":"B36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J Exp Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1046\/j.1365-2133.2002.04743.x","article-title":"Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial","volume":"146","author":"Bhushan","year":"2002","journal-title":"Br J Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nm1605","article-title":"Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis","volume":"13","author":"Conrad","year":"2007","journal-title":"Nat Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/0128071-200910010-00009","article-title":"Efalizumab: a review of its use in the management of chronic moderate-to-severe plaque psoriasis","volume":"10","author":"Frampton","year":"2009","journal-title":"Am J Clin Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1046\/j.1523-1747.2003.12563.x","article-title":"The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders","volume":"121","author":"Schon","year":"2003","journal-title":"J Invest Dermatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nm.3860","article-title":"Common clonal origin of central and resident memory T cells following skin immunization","volume":"21","author":"Gaide","year":"2015","journal-title":"Nat Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","article-title":"Psoriasis and HLA-Cw6","volume":"102","author":"Tiilikainen","year":"1980","journal-title":"Br J Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/1523-1747.ep12345600","article-title":"Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study","volume":"106","author":"Schmitt-Egenolf","year":"1996","journal-title":"J Invest Dermatol."},{"key":"B44","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.4049\/jimmunol.155.8.4078","article-title":"Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris","volume":"155","author":"Menssen","year":"1995","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ng.3379","article-title":"Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases","volume":"47","author":"Lenz","year":"2015","journal-title":"Nat Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1084\/jem.20151093","article-title":"Melanocyte antigen triggers autoimmunity in human psoriasis","volume":"212","author":"Arakawa","year":"2015","journal-title":"J Exp Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3389\/fimmu.2018.00954","article-title":"Human leukocyte antigen-class I alleles and the autoreactive T cell response in psoriasis pathogenesis","volume":"9","author":"Prinz","year":"2018","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1084\/jem.20160258","article-title":"Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a","volume":"213","author":"Cheung","year":"2016","journal-title":"J Exp Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin","volume":"131","author":"Bovenschen","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/jdv.12288","article-title":"The imbalance of Th17 cells and CD4+CD25highFoxp3+ Treg cells in patients with atopic dermatitis","volume":"28","author":"Ma","year":"2013","journal-title":"J Euro Acad Dermatol Venereol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/sji.12404","article-title":"Characterization of Th17 and FoxP3(+) treg cells in paediatric psoriasis patients","volume":"83","author":"Zhang","year":"2016","journal-title":"Scand J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J Autoimmun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/1523-1747.ep12560826","article-title":"Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization","volume":"90","author":"Kahari","year":"1988","journal-title":"J Invest Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1172\/JCI118071","article-title":"T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors","volume":"96","author":"Kuwana","year":"1995","journal-title":"J Clin Invest."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6138","DOI":"10.4049\/jimmunol.164.12.6138","article-title":"Analysis of soluble and cell surface factors regulating anti-DNA topoisomerase I autoantibody production demonstrates synergy between Th1 and Th2 autoreactive T cells","volume":"164","author":"Kuwana","year":"2000","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13075-016-0993-2","article-title":"Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma","volume":"18","author":"Fava","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3389\/fimmu.2018.02390","article-title":"Autologous hematopoietic stem cell transplantation for treatment of systemic sclerosis","volume":"9","author":"Del","year":"2018","journal-title":"Front Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1684\/ecn.2013.0325","article-title":"T cell abnormalities in systemic sclerosis with a focus on Th17 cells","volume":"23","author":"Brembilla","year":"2012","journal-title":"Eur Cytokine Netw."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3389\/fimmu.2018.02356","article-title":"Regulatory T cells in systemic sclerosis","volume":"9","author":"Frantz","year":"2018","journal-title":"Front Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1046\/j.1365-2133.2000.03901.x","article-title":"Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay","volume":"143","author":"Eming","year":"2000","journal-title":"Br J Dermatol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cei.12566","article-title":"T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid","volume":"180","author":"Pickford","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J Clin Invest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.4049\/jimmunol.1401081","article-title":"Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells","volume":"193","author":"Eming","year":"2014","journal-title":"J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3389\/fimmu.2017.01992","article-title":"Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4(+) T Cells","volume":"8","author":"Sezin","year":"2017","journal-title":"Front Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jid.2017.06.022","article-title":"Mechanisms causing loss of keratinocyte cohesion in pemphigus","volume":"138","author":"Spindler","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jaci.2012.01.062","article-title":"An update on the role of human dendritic cells in patients with atopic dermatitis","volume":"129","author":"Novak","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","article-title":"Does \u201cautoreactivity\u201d play a role in atopic dermatitis?","volume":"129","author":"Tang","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","article-title":"Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema","volume":"124","author":"Zeller","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaci.2011.02.043","article-title":"Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis","volume":"128","author":"Balaji","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2133.2010.10090.x","article-title":"The role of T-cell reactivity towards the autoantigen alpha-NAC in atopic dermatitis","volume":"164","author":"Heratizadeh","year":"2011","journal-title":"Br J Dermatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.4049\/jimmunol.1500351","article-title":"alpha-NAC-specific autoreactive CD8+ T cells in atopic dermatitis are of an effector memory type and secrete IL-4 and IFN-gamma","volume":"196","author":"Roesner","year":"2016","journal-title":"J Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2340\/00015555-1882","article-title":"Regulatory T-cell subsets with acquired functional impairment: important indicators of disease severity in atopic dermatitis","volume":"95","author":"Gaspar","year":"2015","journal-title":"Acta Derm Venereol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/all.12712","article-title":"Foxp3(+) regulatory T cells are expanded in severe atopic dermatitis patients","volume":"70","author":"Roesner","year":"2015","journal-title":"Allergy."},{"key":"B89","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European dermatology forum consensus in collaboration with the European academy of dermatology and venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/ddg.13538","article-title":"S3 Guideline for the treatment of psoriasis vulgaris, update - short version part 2 - special patient populations and treatment situations","volume":"16","author":"Nast","year":"2018","journal-title":"J Dtsch Dermatol Ges."},{"key":"B91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","volume":"136","author":"Krueger","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/jdv.14979","article-title":"Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study","volume":"32","author":"Iversen","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13879","article-title":"Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells","author":"Boniface","year":"2019","journal-title":"Exp Dermatol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","article-title":"Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure","volume":"77","author":"Liu","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science."},{"key":"B97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","article-title":"Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study","volume":"20","author":"Fassas","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"B98","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fimmu.2018.00410","article-title":"Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant","volume":"9","author":"Massey","year":"2018","journal-title":"Front Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/art.40380","article-title":"Blockade of treg cell differentiation and function by the interleukin-21-mechanistic target of rapamycin axis via suppression of autophagy in patients with systemic lupus erythematosus","volume":"70","author":"Kato","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet."},{"key":"B101","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jaad.2018.10.070","article-title":"Topical use of mammalian target of rapamycin inhibitors in dermatology: a systematic review with meta-analysis","volume":"80","author":"Leducq","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B104","doi-asserted-by":"crossref","first-page":"220.213","DOI":"10.4049\/jimmunol.198.Supp.220.13","article-title":"IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases","volume":"198","author":"Kannan","year":"2017","journal-title":"J. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.immuni.2015.08.019","article-title":"Differential roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation","volume":"43","author":"Maxwell","year":"2015","journal-title":"Immunity."},{"key":"B106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:11:42Z","timestamp":1694909502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2019.01198"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01198","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"article-number":"1198"}}